Best stocks to invest in – DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track



Best stocks to invest in

On Jun 17, we issued an updated research report on NY-based DENTSPLY Sirona Inc. XRAY – a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products. The company currently carries a Zacks Rank #3 (Hold).

Post the recent merger with Sirona, DENTSPLY made a promising start to 2016. The company reported a better-than-expected first quarter with both earnings and revenues steering past the Zacks Consensus Estimate. Net sales increased 17.7% on a year-over-year basis to $772.6 million,

Growth at the company was primarily driven by its innovative products like WaveOne GOLD, X-Smart iQ, VDW and CONNECT Drive which are expected to expand customer base in Europe. The DENTSPLY-Sirona merger is expected to generate extensive cost savings ($125 million) by the third year of completion. A strong balance sheet and cash flow statement provide scope for further investments on product development, acquisitions and share repurchases.

DENTSPLY’s dual branding strategy, product innovation, growth opportunities in emerging markets (especially from Asia-Pacific & the Middle East/Africa), diversified product portfolio and recurring revenue base are key growth catalysts. The company provided a positive guidance, with revenue growth projected at 4% to 6% at constant currency for full-year 2016. Adjusted earnings are forecasted in the band of $2.70 to $2.80 per share.

On the flip side, apart from a series of macroeconomic headwinds, currency fluctuation continues to be the major dampener for the stock. In fact, strengthening of the U.S. dollar against Euro and other emerging market currencies impacted the company’s growth trajectory. A persistent decline in sales, accompanied by higher capital expenditure for product development kept margins under pressure.


Stocks to Consider

Better-ranked stocks in the same space include Halyard Health HYH, CR Bard BCR and CONMED Corporation CNMD. Halyard Health sports a Zacks Rank 1 (Strong Buy) while the other two stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BARD C R INC (BCR): Free Stock Analysis Report
 
CONMED CORP (CNMD): Free Stock Analysis Report
 
DENTSPLY SIRONA (XRAY): Free Stock Analysis Report
 
HALYARD HEALTH (HYH): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Comments

– Best stocks to invest in

Learn How To Be #1 on Google Results



Source link